Introduction
noninfectious HIV retroviral particles have been Previous work has suggested the possibility of utilizing described in cells expressing HIV genomes mutagenized the nonproducer F12-HIV genome as a potential in gag 8 or env 9 genes, or in cells co-infected with a mix approach for anti-HIV gene therapy. F12-HIV is a HIV-1 of infectious and pol-defective HIV virions that, however, nondefective genome 1 that encodes for a heavily altered are not able to influence the life cycle of an integrated structural viral protein pattern 2 and it is able to induce, infectious HIV. 10 Short-time (24-48 h) CD4-independent in the host cells, resistance to replication-competent HIV resistance to HIV superinfection of acutely infected CEM superinfection through a mechanism not mediated by cells after challenge with high multiplicity of infectious down-regulation of the CD4 HIV receptor. 3, 4 The F12-HIV was recently reported.
HIV-induced homologous viral interference has no
The recovery through the retroviral vector strategy of counterparts in the HIV system. In fact, cells chronically recombinant retroviral particles carrying the nonproinfected by a noncytopathic HIV-2 strain, which still ducer F12-HIV genome 4 has provided the possibility of express the CD4 receptor, could be superinfected with utilizing the interfering capacity of such an HIV variant either the HIV-1 or HIV-2 strains. 5 In the same way, no in pre-clinical studies of anti-HIV gene therapy. Theoretiviral interference was observed in PM1 cells chronically cally, any anti-HIV reagent (in chemotherapy as well as infected with nonsyncytium-inducing HIV isolates and in immuno-or gene therapy) should also act when the able to express the CD4 receptor. 6 The crucial role played infection has already occurred. Thus, the ability to inhibit by the CD4 receptor in HIV interference was also conthe spreading HIV from infected cells could be a valuable firmed by the block by anti-CD4 antibodies of HIV superproperty of any candidate molecule for an approach in infection in ACH2 cells chronically infected by a single gene therapy. For these reasons an experimental model copy of the HIV/LAI strain. resistance gene, we previously obtained an F12-HIVNo variations in the cell growth between D10 and T-D10 cells were observed (data not shown). In addition, based mouse/human amphotropic pseudotype that has been shown to be a potent anti-HIV reagent in acutely the molecular, biological and virological features of D10 cells were unaffected by the transduction and expression HIV infected CEMss cell clones, 4 but whose effects on HIV chronically infected cells could not be evidenced. In of the N2 retroviral vector alone (data not shown). Similarly, the expression of the truncated form of the NGFr fact, the selection of F12-HIV expressing cell clones (that was necessary considering that only about 30% of the did not influence per se the HIV life cycle, in any acutely or chronically HIV infected cells analyzed (including D10 uncloned G418 resistant cell population has been shown to co-express the F12-HIV genome 4 ) among a transduced cells) (not shown).
In order to obtain a control cell population, CEMss HIV-1 chronically infected cell population was hampered by the fact that F12-HIV viral proteins, even if they generhomogeneously expressing the NFHN vector (CEM1D) were obtained by the same procedure. We assessed that ate an altered protein pattern (whose markers are the lack of gp160 env cleavage and a poorly processed p55 gag the insertion of the NGFr c-DNA did not lead to modifications in the F12-HIV phenotype, specifically in the precursor 2 ) could not be distinguished from those expressed by the endogenous replication-competent HIV.
block of superinfecting HIV. Southern blot analysis demonstrated that the F12-HIVThus, the previously described retroviral construct was modified by inserting the c-DNA of the human nerve NGFr construct was integrated into the T-D10 DNA without any apparent deletions (Figure 3a ). In addition, the growth factor receptor (NGFr) truncated in its cytoplasmic domain in place of the F12-HIV nef gene. The
Southern blot analysis performed after 8 months of culture showed an invariable DNA pattern ( Figure 3b ) indiexpression of the marker gene under the control of the F12-HIV promoter allowed the selection of cell popucating that no deletions, rearrangements and/or recombination products between the two different HIV variants lations homogeneously expressing the interfering viral genome without the need of cell cloning.
stably integrated in to T-D10 cells even after a long cultivation period. An HIV-1 chronically infected Hut-78 cell clone (D10) Results cells is superimposable to that obtained from uninfected CEMss cells homogenously expressing the NFHN conInfection, integration and expression of anti-HIV struct (CEM1D); and (2) in T-D10 cells, the amount of amphotropic pseudotype were not disturbed by the viral RNA produced by the replication-competent HIV expression of endogenous replication-competent HIV-1 seems quantitatively and qualitatively unaltered with D10 cells were cocultivated for 48 h with a producer respect to that observed in D10 cells. AM12 12 cell clone releasing an amphotropic retrovirus The demonstration that all the F12-HIV proteins carrying the N2/F12-HIV-NGFr (NFHN) retroviral con-(which are immunologically indistinguishable from those struct ( Figure 1 ). Taking advantage of the ability of the encoded by replication-competent HIV but whose pattern transduced cells to express the NGF receptor on the cell is heavily altered, mainly in gag and env processing) 2 membrane, 5 × 10 6 D10 cells (that do not express the NGF were expressed in T-D10 cells could not be formally achreceptor, see Figure 2a ) were exposed to a first cycle of ieved. Only an increased amount of env gp160 precursor positive immunoselection 48 h after cocultivation. Fluorin the supernatant distinguishes the T-D10 viral pattern escence activated cell sorter (FACS) analysis for the NGFr from that of D10 cells (Figure 5a ), whereas no substantial showed that only a fraction of these cells were transdifferences in intracellular viral protein patterns could be duced (Figure 2b ). In order to obtain a homogeneously detected (Figure 5b ). transduced D10 cell population, a second immunoselecFinally, T-D10, as well as D10 cells, showed a downtion cycle was carried out a few days later. FACS analysis regulation of the CD4 receptor (data not shown). (Figure 2c ) showed that Ͼ95% of the selected cells expressed the NGFr. This selection protocol allowed us
Retrovirions released from T-D10 cells were to exclude that the recovered T-D10 cells were derived noninfectious from a mono-or even oligoclonal transduced cell
The main goal of this work was to verify whether the population.
expression of the NFHN retroviral vector could interfere with the life cycle of infectious HIV integrated in D10 cells. For this purpose, we evaluated the presence of retrovirions in T-D10 culture supernatants by reverse transcriptase (RT) assay and viral titration. As shown in Figure 6 , no significant variation in the RT level compared with that from D10 supernatants was detected in T-D10 supernatants. Conversely, a dramatic infectivity impairment of the virions released from T-D10 cells was results were indifferently obtained when C8166 or CEMss single copy of proviral HIV per cell 13 ) were concomitantly amplified in the same experimental conditions. As cells were utilized for the titration of supernatants from either D10 or T-D10 cells.
Figure 4 Northern blot of 30 mg of total RNA from CEMss cells transduced and homogenously expressing the NFHN retroviral construct (CEM 1D), D10 or T-D10 cells. RNA was hybridized either with the Figure 3 (a) Southern blot analysis of XbaI-digested genomic DNA from: NGFr probe (a) or with a probe recognizing the U3 region of the HIV a NFHN-transduced AM12 cell clone selected as a producer clone (clone LTR (b). RNA amounts were normalized using a probe specific for the 1); Hut-78 cells (negative control); D10 cells; and NFHN-transduced D10 human GAPDH. Molecular sizes (in kilobases) of the major F12-HIV cells (T-D10). (b) Genomic
shown in Figure 7c , a signal generated by the amplification of HIV nef sequences was detectable also in lysates We were interested in establishing at which step the life cycle of aberrant, noninfectious T-D10 retrovirions from only two 8E5 cells, thus demonstrating the high sensitivity of this PCR assay. Then, the absence of PCR signal was blocked. Highly HIV sensitive CEMss cells were thus challenged by equivalent doses of retrovirions from D10 in lysates from CEMss cells infected with the TD10 supernatant could indeed be considered the consequence of the or T-D10 cell supernatants. Cell lysates were tested by PCR at different time-points after infection. As shown in lack of even few neo-synthetized HIV c-DNA copies. Similar results were also obtained through the ampli- Figure 7 , by amplifying cell lysates obtained 24 h after infection with nef-specific oligoprimers (nef gene is adjacfication of cell lysates recovered at earlier times after infection (ie 6 and 12 h) (not shown), thus indicating that ent to the retrotranscription start site, ie the primer binding site), only in cells infected with the D10 supernatant in challenged CD4 + human cells the retrotranscription process of T-D10 viral RNA was neither completed nor, was a positive signal observed. Lysates from serially decreasing numbers of 8E5 cells (a cell line carrying a possibly, initiated. Retrovirions released from T-D10 cells had no major molecular defects but showed a heavily altered morphology To determine whether the lack of infectivity of the viral particles released from T-D10 cells correlated with some alterations in viral protein composition, radioimmunoprecipitation assay (RIPA) was performed on the semi- 
of TD10 viral inoculum (virus) was lysed and amplified in order to
To verify whether viral genomic RNA was packaged of semi-purified virions. As shown in Figure 8 , no signal was detected when the RNA obtained from T-D10 virions was hybridized with the NGFr probe that specifically recognizes the RNA promoted by the F12-HIV 5′LTR. Furthermore, no apparent variation in signal intensity could be detected when the RNA obtained from either D10 or T-D10 virions was hybridized with a probe specific for the replication-competent HIV (U3 HIV LTR). have been published so far. As also reported for animal Through these data we may exclude that the noninfecretroviruses, the ability of HIV to induce interference tivity correlates with major defects on the molecular congenerally correlates with the block of retroviral receptor tent of T-D10 retrovirions.
exposure. Accordingly, it has been reported that cells We next analyzed the morphology of retrovirions chronically infected by a variety of HIV-1 or HIV-2 isoreleased from T-D10 cells by electron microscopy (EM) lates and CD4 down-regulated could not be superinanalysis. Figure 9d -f shows that retroviral particles fected by any HIV strains. 5 Similarly, CEM cells transemerging from T-D10 cells originate through a substanfected with an HIV mutated in the 5′ rev splice site resist tially unaltered budding process. However, free HIV par-HIV superinfection by down-regulating the CD4 recepticles from T-D10 cells (Figure 9b, c and e) show heavy tor. 14 Conversely, the expression of the nonproducer, morphological alterations compared with infectious HIV nondefective F12-HIV provirus is able to induce a homvirions released from D10 cells (Figure 9a ). In fact, many ologous viral interference, through a mechanism not T-D10 virions seem empty (Figure 9c ), whereas some involving CD4 down-regulation. 3 We were interested in others are oversized (in Figure 9b , the bigger virion measestablishing whether the interfering properties of the F12-ures about 200 nm). Moreover, the most striking abnor-HIV genome previously described in different models of mality detectable in a large number of the T-D10 virions acute infection 3,4,15 could also be observed in cells already is the presence of a nucleus of electron density outside infected by HIV. This was a crucial topic in the perspecthe virion core (Figure 9b, c and e) , where, as a consetive to utilize the F12-HIV genome (or, eventually, part quence of the genomic RNA-protein packaging, a zone of it) in anti-HIV gene therapy. In fact, we feel that the of electron density can normally be observed in infectious possible eradication of HIV infection may correlate, HIV virions (Figure 9a) . beside the protection of lymphocytes from 'de novo' infection, with the elimination or inactivation of the virus from infected lymphocytes and, more importantly, from with an oligosynthetizer from Perkin-Elmer, Norwalk, T-D10 could be considered as a cell population where CT, USA) was added at the 3′ end of the NGFr sequence each cell expresses both F12 and the endogenous repliin the XbaI-HindIII sites. Adaptors including NotI and cation-competent HIV-1 variant.
XhoI sites were inserted in the SacI-KpnI sites of the T-D10 cells represent a stable and reliable model of pUc19 polylinker at the 5′ end of the NGFr-SPA condoubly HIV infected cells as demonstrated by the lack of struct. The nef deleted F12-HIV genome was obtained by XhoI digestion of the previously described N2-F12-HIV rearrangements with the co-expressed replication-comnef-retroviral construct, 4 and inserted in the newly crepetent HIV, even after 8 months of culture. In addition, ated XhoI site of the NGFr/SPA construct. A molecular no reciprocal interference in the HIV-RNA expression clone of the F12-HIV genome inserted in the same orienwas shown and no major differences between D10 and tation as the NGFr c-DNA was selected by restriction T-D10 viral protein patterns were observed when either analysis. Finally, the F12-HIV-NGFr-SPA construct was the viral particles or the cell extracts were analyzed by excised by NotI digestion and inserted into an N2 retrovi-RIPA.
ral vector 18 where a NotI site was added as a second clonBy EM we observed that T-D10 cells released a large ing site besides the XhoI site. NFHN (Figure 1 ) is the number of aberrant retrovirions that may account for the retroviral construct where the F12-HIV-NGFr-SPA conimpressive reduction in infectivity of the T-D10 cell struct was inserted in the opposite orientation with supernatants. Besides large or empty virions, T-D10 cells respect to the N2 retroviral vector. release retroviral particles where a region of electron density from the core is clearly detectable. The nature of such Cell cultures, transfections and infections an alteration is unclear. However, our dot blot data indiHut-78, D10, T-D10, CEM1D, CEMss, 8E5 13 and C8166 cate that no genomic RNA from the F12-HIV genome cells were maintained in RPMI 1640 medium sup-(whose packaging site is unaltered) 1 was carried by the plemented with 10% decomplemented fetal calf serum T-D10 retrovirions. Thus, the abnormal zone of electron (FCS). GP+E86, 19 AM12 12 and NIH 3T3 cells were grown density observed could not originate from an altered in Dulbecco's modified minimal essential medium suppackaging of F12-HIV genomic RNA.
plemented with 10% decomplemented FCS. For G418 Results from PCR analyses showed that after the chal-(GIBCO-BRL, Gaithersburg, MD, USA; 70% activity) lenge of highly HIV susceptible CEMss cells with T-D10 selection, packaging cells were grown in 0.5 mg of G418 retrovirions (that carried exclusively viral RNA from the per ml, whereas T-D10 cells were grown in the presence infectious HIV-1 endogenous in D10 cells), no retroof 0.25 mg/ml of the antibiotic. transcription products could be detected, demonstrating GP+E86 ecotropic packaging cells were transfected their inability to infect, even abortively, target cells. Conwith the NFHN retroviral construct as previously sidering that T-D10 retrovirions possess apparently nordescribed. 4 Supernatants were collected after 48 h and mal amounts of env gp120 glycoprotein, a block in the used to infect AM12 cells (three cycles of infection, 8 h fusion process or in retrotranscription initiation could each). After an additional 48 h, infected AM12 cell culthus be inferred.
tures were selected in G418 and resistant cell clones were To our knowledge, this is the first time that the use of obtained 20 days later. a retroviral vector able to inhibit the infectivity of HIV Producer AM12 cell clones were selected on the basis released from chronically infected cells has been shown. of a detailed molecular characterization, ie analysis This can provide a means to study a potential anti-HIV through Southern blot of the NFHN retroviral construct gene therapy approach based on an interfering HIV genintegration (only AM12 clones integrating a single copy ome effective in blocking HIV infection. It is tempting to of the full-length NFHN construct, as detectable by speculate that these studies may also provide an insight restriction enzyme analyses, were selected), detection by into AIDS pathogenesis. For example, in long-term nonNorthern blot of the MLV 5′LTR-3′LTR full length viral progressor HIV seropositive patients, the limited spread RNA and analysis by FACS of the NGFr cell membrane of infectious HIV might be due, at least in part, to the expression (data not shown). Retroviral titers ranged presence and expression of defective HIV genomes. Interfrom 5 × 10 3 to 10 4 colony forming units/ml on NIH 3T3-est in the role of defective interfering HIV genomes based titration assay as previously described.
18
and/or particles in the development of AIDS pathogenIn order to transduce either uninfected CEMss cells or esis has recently increased due to the observations about D10 cells, cocultivation experiments were performed an apparent discrepancy between the relatively low with a producer AM12 cell clone for 48 h. To remove amounts of infectious HIV (as detected by biological residual packaging cells, three adherence cycles were perassays) and the high number of viral RNA copies (as formed. assessed by highly sensitive molecular assays) detectable Both HIV infectivity on C8166 cells and reverse tranin the serum of AIDS patients. 16 This evidence could scriptase activities were measured as previously reflect the presence of a high number of HIV defective reported 15,20 on supernatants obtained from cells seeded particles that could play an important role in AIDS in logarithmic growth phase 2 days before collection. In particular, reverse transcriptase assay was performed by pathogenesis.
clarifying cell supernatants for 15 min at 10 000 g. One the pUc19 vector; (2) the NGFr gene obtained from the milliliter of supernatant was then ultracentrifuged for 15 pUc19 plasmid by SacI-XbaI digestion; and (3) a 316 bp min at 200 000 g and resuspended in 100 l of TNE buffer fragment of the c-DNA of the human glyceraldehyde-3-(0.1 m NaCl, 0.01 m Tris-HCl pH 7.4 and 0.001 m EDTA) phosphatedehydrogenase (GAPDH) (Ambion, Austin, plus 0.1% (v/v) Triton X-100. Thirty microliters of resus-TX, USA) derived from exons 5-8. pended viral pellet were then diluted in a final volume PCR analyses were performed as described 21 ried out by using nef-specific oligoprimers (whose stopped by adding 0.5 ml of 0.5 m sodium pyrophosphate sequences are: oligoprimer 'forward', from nt 8797 to nt pH 5 and 0.6 ml of cold 20% trichloracetic acid. The 8821; oligoprimer 'reverse', from nt 9417 to nt 9395; the samples were then allowed to precipitate at 4°C for 30 numeration refers to the sequence of the HIV-1/Hxb2c min and subsequently filtered through 0.45 m nitrocelmolecular clone, GeneBank accession number K03455) lulose filters (Sartorius, Gottingen, Germany). Lastly, the able to recognize the replication-competent HIV-1 filters were dried and radioactivity counted in a ␤-counendogenous in D10 cells. Amplification products were ter. Values were expressed as c.p.m. incorporated into run in 1.8% agarose, blotted and hybridized with a ranacid-insoluble material/ml of supernatant and nordom primed 32 P-labeled fragment originated from XhoImalized for 10 6 cells. RT values obtained from negative EcoRV digestion of Hxb2c HIV-1 nef gene. As control, cell controls (ie supernatants from both uninfected Hut-78
lysates from challenged CEMss cells were also amplified and Hut-78/F12 cells, the latter ones being a cell clone with PCO3 and PCO4 human ␤-globin-specific primers, expressing the whole F12-HIV genome, included a fulland amplification products were hybridized with the length HIV RT enzyme, but failing to release even RS06-specific probe.
23 aberrant retroviral particles 1 ) were superimposable to the Virionic RNA was obtained from 30 ml of supernatants background assay levels (ie 10 3 -1.5 × 10 3 c.p.m./ml). of 10 6 cells/ml cultures, filtered with a 0.22 m poresized membrane, and ultracentrifuged on a 20% sucrose FACS analyses and positive cell immunoselection cushion (150 min, 4°C, 95 000 g). RNA was extracted by The CD4 receptor was detected by direct immunofluothe RNA-FastI method and immobilized through a dotrescence using a phycoerythrin-conjugated Leu3a (1:20 blot apparatus to a Hybond-N membrane. Hybridizadiluted, 60 min at 4°C) monoclonal antibody (MoAb) tions were performed with the molecular probe (Becton Dickinson, Mountain View, CA, USA) following described above. the manufacturer's recommendations and analyzed by a Intracellular HIV-related proteins were detected by a cytofluorimeter (FAC-scan, LysisII program, Becton RIPA performed as described. 2 In order to detect viral Dickinson).
proteins in the supernatants, 200 l of supernatants from NGFr membrane expression was measured by indirect 35 S cysteine +
35
S methionine metabolically labeled 2 cells immunofluorescence 21 utilizing the anti-NGFr MoAb 20.4 (at a concentration of 10 6 /ml) were immunoprecipitated (American Type Culture Collection, Rockville, MD, with HIV-positive pooled human sera. RIPA was perfor-USA).
med on viral pellets after ultracentrifugation on a 20% Positive NGFr-based cell immunoselection was perforsucrose cushion (90 min, 4°C, 120 000 g) of filtered (0.22 med by incubating 3 × 10 6 cells/ml in phosphate-buffered ) supernatants. saline (PBS) with 2.5% FCS in the presence of anti-NGFr MoAb at 4°C for 60 min in a blood mixer. Cells were then washed and resuspended in PBS/FCS buffer at Electron microscopy (EM) analysis 5 × 10 6 /ml in the presence of Dynabeads (Dynal, Oslo, Cells were washed three times with PBS, fixed in 2.5% Norway) conjugated with anti-mouse IgG antibodies, in glutaraldehyde for 24 h at 4°C, post-fixed in 1% osmium a proportion of about three beads per cell. After 45 min tetroxide for 1 h at 4°C. Cells were then dehydrated in at 4°C in constant slow rotation, cells were washed and graded ethilic alcohol and embedded in EPON 812 resin. reseeded in the appropriate medium supplemented with Ultrathin sections were cut and stained for 2 min with 20% FCS.
uranyl acetate and for 7 min in lead hydroxide. The sections were finally observed and photographed using a DNA, RNA and protein analyses Genomic DNA was prepared by standard methods, 22 Philips CM10 electron microscope (Eindhoven, The separated by a 0.8% agarose gel after appropriate digesNetherlands). tion and blotted on to a nylon filter (Hybond-N; Amersham, Bucks, UK). Filters were then hybridized with a 32 P-labeled F12-HIV full-length molecular probe.
